Skip to contentV
Vsee Health, Inc.
V
VSEEVsee Health, Inc. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$6.26M$6.26Mderived+67.7% vs Q4 2024 Net Income-$7.85M-$7.85MderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vsee Health, Inc. · CIK 1864531 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$2,807,654+17.9% Operating Incomederived-$4,137,987N/M Operating Cash Flowderived-$1,926,101N/M Free Cash Flowderived-$1,933,253N/M Margins · derivedGross margin44.8%−18.9 pt vs Q4 2024
Operating margin-66.1%+15.0 pt vs Q4 2024
Net margin-125.4%−39.5 pt vs Q4 2024
ended Dec 31, 2025 · filed Mar 31, 2026 · 90 d after period end